Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mason W Freeman

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Infection and Immunity|March 14, 2022
Correction for Jeyaseelan et al., "Distinct Roles of Pattern Recognition Receptors CD14 and Toll-Like Receptor 4 in Acute Lung Injury"Samithamby Jeyaseelan, Hong Wei Chu, Scott K Young, et al.
Diabetes, Obesity & Metabolism|July 6, 2023
Bexagliflozin as an adjunct to metformin for the treatment of type 2 diabetes in adults: A 24-week, randomized, double-blind, placebo-controlled trialYuan-Di Halvorsen, Annie L Conery, John Paul Lock, et al.
Diabetes, Obesity & Metabolism|July 13, 2019
A 96-week, multinational, randomized, double-blind, parallel-group, clinical trial evaluating the safety and effectiveness of bexagliflozin as a monotherapy for adults with type 2 diabetesYuan-Di C Halvorsen, Geoffrey A Walford, Joseph Massaro, et al.
Journal of Alzheimer'S Disease : JAD|August 24, 2011
Wild type and Tangier disease ABCA1 mutants modulate cellular amyloid-β production independent of cholesterol efflux activityWoojin S Kim, Andrew F Hill, Michael L Fitzgerald, et al.
European Heart Journal|March 23, 2005
Efficacy and safety of the coadministration of ezetimibe with fenofibrate in patients with mixed hyperlipidaemiaMichel Farnier, Mason W Freeman, Geraldine Macdonell, et al.
The New England Journal of Medicine|July 18, 2019
Case 22-2019: A 65-Year-Old Woman with Weakness, Dark Urine, and DysphagiaMason W Freeman, Ajay K Singh, Amanda C Guidon, et al.
The Journal of Biological Chemistry|June 27, 2002
Naturally occurring mutations in the largest extracellular loops of ABCA1 can disrupt its direct interaction with apolipoprotein A-IMichael L Fitzgerald, Andrea L Morris, Jeongmi S Rhee, et al.
The Journal of Biological Chemistry|September 7, 2004
ATP-binding cassette transporter A1 contains a novel C-terminal VFVNFA motif that is required for its cholesterol efflux and ApoA-I binding activitiesMichael L Fitzgerald, Kei-Ichiro Okuhira, Glenn F Short, et al.
The Journal of Biological Chemistry|September 20, 2002
A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloidKathryn J Moore, Joseph El Khoury, Lea A Medeiros, et al.
Genes & Development|January 10, 2002
C/EBPalpha induces adipogenesis through PPARgamma: a unified pathwayEvan D Rosen, Chung-Hsin Hsu, Xinzhong Wang, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Infection and Immunity|March 14, 2022
Correction for Jeyaseelan et al., "Distinct Roles of Pattern Recognition Receptors CD14 and Toll-Like Receptor 4 in Acute Lung Injury"Samithamby Jeyaseelan, Hong Wei Chu, Scott K Young, et al.
Diabetes, Obesity & Metabolism|July 6, 2023
Bexagliflozin as an adjunct to metformin for the treatment of type 2 diabetes in adults: A 24-week, randomized, double-blind, placebo-controlled trialYuan-Di Halvorsen, Annie L Conery, John Paul Lock, et al.
Diabetes, Obesity & Metabolism|July 13, 2019
A 96-week, multinational, randomized, double-blind, parallel-group, clinical trial evaluating the safety and effectiveness of bexagliflozin as a monotherapy for adults with type 2 diabetesYuan-Di C Halvorsen, Geoffrey A Walford, Joseph Massaro, et al.
Journal of Alzheimer'S Disease : JAD|August 24, 2011
Wild type and Tangier disease ABCA1 mutants modulate cellular amyloid-β production independent of cholesterol efflux activityWoojin S Kim, Andrew F Hill, Michael L Fitzgerald, et al.
European Heart Journal|March 23, 2005
Efficacy and safety of the coadministration of ezetimibe with fenofibrate in patients with mixed hyperlipidaemiaMichel Farnier, Mason W Freeman, Geraldine Macdonell, et al.
The New England Journal of Medicine|July 18, 2019
Case 22-2019: A 65-Year-Old Woman with Weakness, Dark Urine, and DysphagiaMason W Freeman, Ajay K Singh, Amanda C Guidon, et al.
The Journal of Biological Chemistry|June 27, 2002
Naturally occurring mutations in the largest extracellular loops of ABCA1 can disrupt its direct interaction with apolipoprotein A-IMichael L Fitzgerald, Andrea L Morris, Jeongmi S Rhee, et al.
The Journal of Biological Chemistry|September 7, 2004
ATP-binding cassette transporter A1 contains a novel C-terminal VFVNFA motif that is required for its cholesterol efflux and ApoA-I binding activitiesMichael L Fitzgerald, Kei-Ichiro Okuhira, Glenn F Short, et al.
The Journal of Biological Chemistry|September 20, 2002
A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloidKathryn J Moore, Joseph El Khoury, Lea A Medeiros, et al.
Genes & Development|January 10, 2002
C/EBPalpha induces adipogenesis through PPARgamma: a unified pathwayEvan D Rosen, Chung-Hsin Hsu, Xinzhong Wang, et al.
Pageof 7